Global Meningococcal Vaccine Competitive Landscape Professional Research Report 2024

Global Meningococcal Vaccine Competitive Landscape Professional Research Report 2024

Research Summary

The meningococcal vaccine is a type of immunization that helps protect against meningococcal disease, which is caused by the bacterium Neisseria meningitidis. Meningococcal disease can lead to severe infections like meningitis (inflammation of the membranes surrounding the brain and spinal cord) and septicemia (bloodstream infection). The vaccine stimulates the body’s immune system to produce a response against the specific strains of meningococcal bacteria included in the vaccine. There are different types of meningococcal vaccines available, including those targeting serogroups A, B, C, W, and Y. Some vaccines are conjugate vaccines, which offer longer-lasting protection and are often recommended for infants, adolescents, and young adults. Other vaccines may target specific high-risk populations or outbreaks. The meningococcal vaccine is typically administered through injection, and receiving the vaccine helps reduce the risk of meningococcal disease and its potentially severe complications. It is often recommended for individuals at increased risk, such as adolescents, college students living in dormitories, military recruits, and travelers to areas with high meningococcal disease rates.

According to DIResearch's in-depth investigation and research, the global Meningococcal Vaccine market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med, China National Biotec Group, Hualan Bio, Zhifei, Walvax etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Meningococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Meningococcal Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Meningococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Meningococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Meningococcal Vaccine Include:

Novartis

GSK

Merck

CSL

Baxter

JN International Medical Corporation

Serum Institute of India

Bio-Med

China National Biotec Group

Hualan Bio

Zhifei

Walvax

Meningococcal Vaccine Product Segment Include:

Meningtits A

Polysaccharide Meningtitis AC

Meningitis ACYW

Meningococcal Vaccine Product Application Include:

6 Months-15Year

over 3 Year

over 2 Year

over 3 Months

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Meningococcal Vaccine Industry PESTEL Analysis

Chapter 3: Global Meningococcal Vaccine Industry Porter’s Five Forces Analysis

Chapter 4: Global Meningococcal Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Meningococcal Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Meningococcal Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Meningococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources